{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:25:21Z","timestamp":1780662321471,"version":"3.54.1"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s11010-024-05110-0","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T06:02:32Z","timestamp":1725948152000},"page":"1431-1448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["MicroRNAs as promising drug delivery target to ameliorate chronic obstructive pulmonary disease using nano-carriers: a comprehensive review"],"prefix":"10.1007","volume":"480","author":[{"given":"Vamika","family":"Khanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"5110_CR1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3390\/biom13030476","volume":"13","author":"F Gomes","year":"2023","unstructured":"Gomes F, Cheng SL (2023) Pathophysiology, therapeutic targets, and future therapeutic alternatives in COPD: focus on the importance of the cholinergic system. Biomolecules 13:476","journal-title":"Biomolecules"},{"key":"5110_CR2","unstructured":"WHO (2023) Chronic obstructive pulmonary disease (COPD). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chronic-obstructive-pulmonary-disease-(copd). Accessed 30 Sep 2023"},{"key":"5110_CR3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/thoraxjnl-2020-216037","volume":"76","author":"VV Polosukhin","year":"2021","unstructured":"Polosukhin VV, Gutor SS, Du RH, Richmond BW, Massion PP, Wu P, Cates JM, Sandler KL, Rennard SI, Blackwell TS (2021) Small airway determinants of airflow limitation in chronic obstructive pulmonary disease. Thorax 76:1079\u20131088","journal-title":"Thorax"},{"key":"5110_CR4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1183\/09031936.00120609","volume":"35","author":"PT Macklem","year":"2010","unstructured":"Macklem PT (2010) Therapeutic implications of the pathophysiology of COPD. Eur Respir J 35:676\u2013680","journal-title":"Eur Respir J"},{"key":"5110_CR5","first-page":"17","volume":"60","author":"BB Brashier","year":"2012","unstructured":"Brashier BB, Rahul K (2012) Risk factors and pathophysiology of chronic obstructive pulmonary disease (COPD). J Assoc Physicians India 60:17\u201321","journal-title":"J Assoc Physicians India"},{"issue":"9","key":"5110_CR6","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41419-019-1873-x","volume":"10","author":"P Wei","year":"2019","unstructured":"Wei P et al (2019) Transforming growth factor (TGF)-\u03b21-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis. Cell Death Dis 10(9):670","journal-title":"Cell Death Dis"},{"key":"5110_CR7","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/thx.2009.130260","volume":"65","author":"NJ Sinden","year":"2010","unstructured":"Sinden NJ, Stockley RA (2010) Systemic inflammation and comorbidity in COPD: a result of \u201coverspill\u201d of inflammatory mediators from the lungs? Review of the evidence. Thorax 65:930\u2013936","journal-title":"Thorax"},{"key":"5110_CR8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pulmoe.2018.09.006","volume":"25","author":"S Andr\u00e9","year":"2019","unstructured":"Andr\u00e9 S, Conde B, Fragoso E, Bol\u00e9o-Tom\u00e9 JP, Areias V, Cardoso J (2019) COPD and cardiovascular disease. Pulmonology 25:168\u2013176","journal-title":"Pulmonology"},{"key":"5110_CR9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/jcm8010069","volume":"8","author":"F Trinkmann","year":"2019","unstructured":"Trinkmann F, Saur J, Borggrefe M, Akin I (2019) Cardiovascular comorbidities in chronic obstructive pulmonary disease (COPD)\u2014current considerations for clinical practice. J Clin Med 8:69","journal-title":"J Clin Med"},{"key":"5110_CR10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1183\/09031936.00114307","volume":"31","author":"LM Fabbri","year":"2008","unstructured":"Fabbri LM, Luppi F, Begh\u00e9 B, Rabe KF (2008) Complex chronic comorbidities of COPD. Eur Respir J 31:204\u2013212","journal-title":"Eur Respir J"},{"key":"5110_CR11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11739-013-0945-7","volume":"9","author":"J D\u00edez-Manglano","year":"2014","unstructured":"D\u00edez-Manglano J, Barquero-Romero J, Almagro P, Cabrera FJ, L\u00f3pez Garc\u00eda F, Montero L, Soriano JB (2014) COPD patients with and without metabolic syndrome: clinical and functional differences. Intern Emerg Med 9:419\u2013425","journal-title":"Intern Emerg Med"},{"key":"5110_CR12","volume":"102","author":"Q Wang","year":"2023","unstructured":"Wang Q, Su W, Liu J, Zhao D (2023) Advances in the investigation of the role of autophagy in the etiology of chronic obstructive pulmonary disease: a review. Medicine 102:e36390","journal-title":"Medicine"},{"key":"5110_CR13","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/emmm.201100627","volume":"4","author":"A Berndt","year":"2012","unstructured":"Berndt A, Leme AS, Shapiro SD (2012) Emerging genetics of COPD. EMBO Mol Med 4:1144\u20131155","journal-title":"EMBO Mol Med"},{"key":"5110_CR14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1378\/chest.09-0555","volume":"136","author":"ES Wan","year":"2009","unstructured":"Wan ES, Silverman EK (2009) Genetics of COPD and emphysema. Chest 136:859\u2013866","journal-title":"Chest"},{"key":"5110_CR15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1183\/09031936.00121611","volume":"39","author":"A Churg","year":"2012","unstructured":"Churg A, Zhou S, Wright JL (2012) Matrix metalloproteinases in COPD. Eur Respir J 39:197\u2013209","journal-title":"Eur Respir J"},{"key":"5110_CR16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/biomedicines11020448","volume":"11","author":"KH Czarnecka-Chrebelska","year":"2023","unstructured":"Czarnecka-Chrebelska KH, Mukherjee D, Maryanchik SV, Rudzinska-Radecka M (2023) Biological and genetic mechanisms of COPD, its diagnosis, treatment, and relationship with lung cancer. Biomedicines 11:448","journal-title":"Biomedicines"},{"key":"5110_CR17","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.2147\/COPD.S320841","volume":"16","author":"C Ganbold","year":"2021","unstructured":"Ganbold C, Jamiyansuren J, Tumurbaatar A, Bayarmaa A, Enebish T, Dashtseren I, Jav S (2021) The cumulative effect of gene-gene interactions between GSTM1, CHRNA3, CHRNA5 and SOD3 gene polymorphisms combined with smoking on COPD risk. Int J Chron Obstruct Pulmon Dis 16:2857\u20132868","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"5110_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2350-12-24","volume":"12","author":"SL Chappell","year":"2011","unstructured":"Chappell SL et al (2011) The role of IREB2 and transforming growth factor beta-1 genetic variants in COPD: a replication case-control study. BMC Med Genet 12:1\u20137","journal-title":"BMC Med Genet"},{"key":"5110_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00882","author":"A Ortega-Mart\u00ednez","year":"2020","unstructured":"Ortega-Mart\u00ednez A, P\u00e9rez-Rubio G, Ambrocio-Ortiz E et al (2020) The SNP rs13147758 in the HHIP gene is associated with COPD susceptibility, serum, and sputum protein levels in smokers. Front Genet. https:\/\/doi.org\/10.3389\/fgene.2020.00882","journal-title":"Front Genet"},{"key":"5110_CR20","doi-asserted-by":"crossref","first-page":"L377","DOI":"10.1152\/ajplung.00477.2020","volume":"321","author":"A Tam","year":"2021","unstructured":"Tam A, Leclair P, Li LV et al (2021) FAM13A as potential therapeutic target in modulating TGF-\u03b2-induced airway tissue remodeling in COPD. Am J Physiol-Lung Cell Mol Physiol 321:L377\u2013L391","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"key":"5110_CR21","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.3390\/jcm12103366","volume":"12","author":"NL Reynaert","year":"2023","unstructured":"Reynaert NL, Vanfleteren LEGW, Perkins TN (2023) The AGE-RAGE axis and the pathophysiology of multimorbidity in COPD. J Clin Med 12:3366","journal-title":"J Clin Med"},{"key":"5110_CR22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40749-015-0014-x","volume":"1","author":"K Probert","year":"2015","unstructured":"Probert K, Miller S, Kheirallah AK, Hall IP (2015) Developmental genetics of the COPD lung. COPD Res Pract 1:10","journal-title":"COPD Res Pract"},{"key":"5110_CR23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12931-018-0744-9","volume":"19","author":"P Sakornsakolpat","year":"2018","unstructured":"Sakornsakolpat P, Morrow JD, Castaldi PJ, Hersh CP, Boss\u00e9 Y, Silverman EK, Manichaikul A, Cho MH (2018) Integrative genomics identifies new genes associated with severe COPD and emphysema. Respir Res 19:46","journal-title":"Respir Res"},{"key":"5110_CR24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-physiol-021317-121224","volume":"82","author":"EK Silverman","year":"2020","unstructured":"Silverman EK (2020) Genetics of COPD. Annu Rev Physiol 82:413\u2013431","journal-title":"Annu Rev Physiol"},{"key":"5110_CR25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/thoraxjnl-2011-200089","volume":"67","author":"ME Ezzie","year":"2012","unstructured":"Ezzie ME, Crawford M, Cho JH et al (2012) Gene expression networks in COPD: microRNA and mRNA regulation. Thorax 67:122\u2013131","journal-title":"Thorax"},{"key":"5110_CR26","volume":"7","author":"F Hassan","year":"2012","unstructured":"Hassan F, Nuovo GJ, Crawford M, Boyaka PN, Kirkby S, Nana-Sinkam SP, Cormet-Boyaka E (2012) MiR-101 and miR-144 regulate the expression of the CFTR chloride channel in the lung. PLoS ONE 7:e50837","journal-title":"PLoS ONE"},{"key":"5110_CR27","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.4049\/jimmunol.1000798","volume":"185","author":"QY Zhu","year":"2010","unstructured":"Zhu QY, Liu Q, Chen JX, Lan K, Ge BX (2010) MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages. J Immunol 185:7435\u20137442","journal-title":"J Immunol"},{"key":"5110_CR28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12931-017-0637-3","volume":"18","author":"SM Moosavi","year":"2017","unstructured":"Moosavi SM, Prabhala P, Ammit AJ (2017) Role and regulation of MKP-1 in airway inflammation. Respir Res 18:154","journal-title":"Respir Res"},{"key":"5110_CR29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1378\/chest.11-2746","volume":"142","author":"S Mizuno","year":"2012","unstructured":"Mizuno S, Bogaard HJ, Gomez-Arroyo J, Alhussaini A, Kraskauskas D, Cool CD, Voelkel NF (2012) MicroRNA-199a-5p is associated with hypoxia-inducible factor-1\u03b1 expression in lungs from patients with COPD. Chest 142:663\u2013672","journal-title":"Chest"},{"key":"5110_CR30","first-page":"463","volume":"10","author":"R Wang","year":"2015","unstructured":"Wang R, Li M, Zhou S, Zeng D, Xu X, Xu R, Sun G (2015) Effect of a single nucleotide polymorphism in miR-146a on COX-2 protein expression and lung function in smokers with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 10:463\u2013473","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"5110_CR31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pupt.2015.08.007","volume":"34","author":"A Ebrahimi","year":"2015","unstructured":"Ebrahimi A, Sadroddiny E (2015) MicroRNAs in lung diseases: recent findings and their pathophysiological implications. Pulm Pharmacol Ther 34:55\u201363","journal-title":"Pulm Pharmacol Ther"},{"key":"5110_CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12931-018-0722-2","volume":"19","author":"YJ Long","year":"2018","unstructured":"Long YJ, Liu XP, Chen SS, Zong DD, Chen Y, Chen P (2018) miR-34a is involved in CSE-induced apoptosis of human pulmonary microvascular endothelial cells by targeting Notch-1 receptor protein. Respir Res 19:21","journal-title":"Respir Res"},{"key":"5110_CR33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.intimp.2017.11.030","volume":"55","author":"W Gu","year":"2018","unstructured":"Gu W, Yuan Y, Yang H, Wu H, Wang L, Tang Z, Li Q (2018) Role of miR-195 in cigarette smoke-induced chronic obstructive pulmonary disease. Int Immunopharmacol 55:49\u201354","journal-title":"Int Immunopharmacol"},{"key":"5110_CR34","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1177\/0960327117741749","volume":"37","author":"H Xue","year":"2018","unstructured":"Xue H, Li M (2018) MicroRNA-150 protects against cigarette smoke-induced lung inflammation and airway epithelial cell apoptosis through repressing p53: microRNA-150 in CS-induced lung inflammation. Hum Exp Toxicol 37:920\u2013928","journal-title":"Hum Exp Toxicol"},{"key":"5110_CR35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184039","volume":"12","author":"J Ikari","year":"2017","unstructured":"Ikari J, Nelson AJ, Obaid J et al (2017) Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease. PLoS ONE 12:e0184039","journal-title":"PLoS ONE"},{"key":"5110_CR36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.toxlet.2017.08.079","volume":"280","author":"H Xu","year":"2017","unstructured":"Xu H, Sun Q, Lu L et al (2017) MicroRNA-218 acts by repressing TNFR1-mediated activation of NF-\u03baB, which is involved in MUC5AC hyper-production and inflammation in smoking-induced bronchiolitis of COPD. Toxicol Lett 280:171\u2013180","journal-title":"Toxicol Lett"},{"key":"5110_CR37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12931-017-0639-1","volume":"18","author":"Y Du","year":"2017","unstructured":"Du Y, Ding Y, Chen X, Mei Z, Ding H, Wu Y, Jie Z (2017) MicroRNA-181c inhibits cigarette smoke\u2013induced chronic obstructive pulmonary disease by regulating CCN1 expression. Respir Res 18:155","journal-title":"Respir Res"},{"key":"5110_CR38","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.2147\/COPD.S104627","volume":"12","author":"H Liu","year":"2017","unstructured":"Liu H, Yin T, Yan W, Si R, Wang B, Chen M, Li F, Wang Q, Tao L (2017) Dysregulation of microRNA-214 and PTEN contributes to the pathogenesis of hypoxic pulmonary hypertension. Int J Chron Obstruct Pulmon Dis 12:1781\u20131791","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"5110_CR39","doi-asserted-by":"crossref","first-page":"e90443","DOI":"10.1172\/jci.insight.90443","volume":"2","author":"ACY Hsu","year":"2017","unstructured":"Hsu ACY, Dua K, Starkey MR et al (2017) MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD. JCI Insight 2:e90443","journal-title":"JCI Insight"},{"key":"5110_CR40","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/COPD.S128031","volume":"12","author":"W Shen","year":"2017","unstructured":"Shen W, Liu J, Zhao G, Fan M, Song G, Zhang Y, Weng Z, Zhang Y (2017) Repression of Toll-like receptor-4 by microRNA-149-3p is associated with smoking-related COPD. Int J Chron Obstruct Pulmon Dis 12:705\u2013715","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"5110_CR41","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2147\/COPD.S120415","volume":"12","author":"H Xu","year":"2017","unstructured":"Xu H, Wu Y, Li L, Yuan W, Zhang D, Yan Q, Guo Z, Huang W (2017) MiR-344b-1-3p targets TLR2 and negatively regulates TLR2 signaling pathway. Int J Chron Obstruct Pulmon Dis 12:627\u2013638","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"5110_CR42","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12964-023-01337-4","volume":"21","author":"A Ahmadi","year":"2023","unstructured":"Ahmadi A, Ahrari S, Salimian J, Salehi Z, Karimi M, Emamvirdizadeh A, Jamalkandi SA, Ghanei M (2023) p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics. Cell Commun Signal 21:314","journal-title":"Cell Commun Signal"},{"key":"5110_CR43","first-page":"10662","volume":"8","author":"L Shi","year":"2015","unstructured":"Shi L, Xin Q, Chai R, Liu L, Ma Z (2015) Ectopic expressed miR-203 contributes to chronic obstructive pulmonary disease via targeting TAK1 and PIK3CA. Int J Clin Exp Pathol 8:10662\u201310670","journal-title":"Int J Clin Exp Pathol"},{"key":"5110_CR44","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2147\/COPD.S83596","volume":"10","author":"H Hu","year":"2015","unstructured":"Hu H, Zhang L, Teng G, Wu Y, Chen Y (2015) A variant in 3\u2032-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD. Int J Chron Obstruct Pulmon Dis 10:1641\u20131649","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"5110_CR45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000374061","volume":"36","author":"S Zhou","year":"2015","unstructured":"Zhou S, Li M, Zeng D, Xu X, Fei L, Zhu Q, Zhang Y, Wang R (2015) A single nucleotide polymorphism in 3\u2019 untranslated region of epithelial growth factor receptor confers risk for pulmonary hypertension in chronic obstructive pulmonary disease. Cell Physiol Biochem 36:166\u2013178","journal-title":"Cell Physiol Biochem"},{"key":"5110_CR46","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.tranon.2018.11.004","volume":"12","author":"S Holm Nielsen","year":"2018","unstructured":"Holm Nielsen S, Willumsen N, Leeming DJ, Daniels SJ, Brix S, Karsdal MA, Genovese F, Nielsen MJ (2018) Serological assessment of activated fibroblasts by alpha-smooth muscle actin (\u03b1-SMA): a noninvasive biomarker of activated fibroblasts in lung disorders. Transl Oncol 12:368\u2013374","journal-title":"Transl Oncol"},{"key":"5110_CR47","first-page":"31","volume":"1","author":"S Bozinovski","year":"2006","unstructured":"Bozinovski S, Vlahos R, Hansen M, Liu K, Anderson GP (2006) Akt in the pathogenesis of COPD. Int J Chron Obstruct Pulmon Dis 1:31\u201338","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"5110_CR48","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.3390\/ijms20112785","volume":"20","author":"P Henrot","year":"2019","unstructured":"Henrot P, Prevel R, Berger P, Dupin I (2019) Chemokines in COPD: from implication to therapeutic use. Int J Mol Sci 20:2785","journal-title":"Int J Mol Sci"},{"key":"5110_CR49","doi-asserted-by":"crossref","first-page":"24661","DOI":"10.1038\/srep24661","volume":"6","author":"H Liu","year":"2016","unstructured":"Liu H, Tao Y, Chen M, Yu J, Li W-J, Tao L, Li Y, Li F (2016) Upregulation of microRNA-214 contributes to the development of vascular remodeling in hypoxia-induced pulmonary hypertension via targeting CCNL2. Sci Rep 6:24661","journal-title":"Sci Rep"},{"key":"5110_CR50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152834","volume":"11","author":"MS Fawzy","year":"2016","unstructured":"Fawzy MS, Hussein MH, Abdelaziz EZ, Yamany HA, Ismail HM, Toraih EA (2016) Association of microRNA-196a2 variant with response to short-acting \u03b22-agonist in COPD: an Egyptian pilot study. PLoS ONE 11:e0152834","journal-title":"PLoS ONE"},{"key":"5110_CR51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/15412555.2020.1780576","volume":"17","author":"L Zhang","year":"2020","unstructured":"Zhang L, Valizadeh H, Alipourfard I, Bidares R, Aghebati-Maleki L, Ahmadi M (2020) Epigenetic modifications and therapy in chronic obstructive pulmonary disease (COPD): an update review. COPD J Chronic Obstr Pulm Dis 17:333\u2013342","journal-title":"COPD J Chronic Obstr Pulm Dis"},{"key":"5110_CR52","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2217\/bmm-2016-0373","volume":"11","author":"H-S Nam","year":"2017","unstructured":"Nam H-S, Izumchenko E, Dasgupta S, Hoque MO (2017) Mitochondria in chronic obstructive pulmonary disease and lung cancer: where are we now? Biomark Med 11:475\u2013489","journal-title":"Biomark Med"},{"key":"5110_CR53","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00210-001-0494-x","volume":"364","author":"T Ichiyama","year":"2001","unstructured":"Ichiyama T, Hasegawa S, Matsubara T, Hayashi T, Furukawa S (2001) Theophylline inhibits NF-\u03baB activation and I\u03baB\u03b1 degradation in human pulmonary epithelial cells. Naunyn Schmiedebergs Arch Pharmacol 364:558\u2013561","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5110_CR54","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.chest.2017.10.031","volume":"153","author":"T Lai","year":"2018","unstructured":"Lai T, Tian B, Cao C et al (2018) HDAC2 suppresses IL17A-mediated airway remodeling in human and experimental modeling of COPD. Chest 153:863\u2013875","journal-title":"Chest"},{"key":"5110_CR55","volume":"10","author":"S-Y Kim","year":"2015","unstructured":"Kim S-Y, Zhang Q, Brunmeir R, Han W, Xu F (2015) SIRT1 interacts with and deacetylates ATP6V1B2 in mature adipocytes. PLoS ONE 10:e0133448","journal-title":"PLoS ONE"},{"key":"5110_CR56","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000500628","volume":"86","author":"N Ma","year":"2019","unstructured":"Ma N, Deng TT, Wang Q et al (2019) Erythromycin regulates cigarette smoke-induced proinflammatory mediator release through Sirtuin 1-nuclear factor \u03baB axis in macrophages and mice lungs. Pathobiology 86:237\u2013247","journal-title":"Pathobiology"},{"key":"5110_CR57","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116800","volume":"235","author":"J Ding","year":"2019","unstructured":"Ding J, Li F, Cong Y, Miao J, Wu D, Liu B, Wang L (2019) Trichostatin A inhibits skeletal muscle atrophy induced by cigarette smoke exposure in mice. Life Sci 235:116800","journal-title":"Life Sci"},{"key":"5110_CR58","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2018.05.023","volume":"832","author":"MG Matera","year":"2018","unstructured":"Matera MG, Calzetta L, Gritti G, Gallo L, Perfetto B, Donnarumma G, Cazzola M, Rogliani P, Donniacuo M, Rinaldi B (2018) Role of statins and mevalonate pathway on impaired HDAC2 activity induced by oxidative stress in human airway epithelial cells. Eur J Pharmacol 832:114\u2013119","journal-title":"Eur J Pharmacol"},{"key":"5110_CR59","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.2147\/COPD.S113978","volume":"11","author":"L Gan","year":"2016","unstructured":"Gan L, Li C, Wang J, Guo X (2016) Curcumin modulates the effect of histone modification on the expression of chemokines by type II alveolar epithelial cells in a rat COPD model. Int J Chron Obstruct Pulmon Dis 11:2765\u20132773","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"5110_CR60","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ejphar.2016.09.015","volume":"791","author":"SD Alipoor","year":"2016","unstructured":"Alipoor SD, Adcock IM, Garssen J, Mortaz E, Varahram M, Mirsaeidi M, Velayati A (2016) The roles of miRNAs as potential biomarkers in lung diseases. Eur J Pharmacol 791:395\u2013404","journal-title":"Eur J Pharmacol"},{"key":"5110_CR61","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1183\/09031936.00091513","volume":"43","author":"S Molina-Pinelo","year":"2014","unstructured":"Molina-Pinelo S, Pastor MD, Suarez R et al (2014) MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD. Eur Respir J 43:1740\u20131749","journal-title":"Eur Respir J"},{"key":"5110_CR62","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.intimp.2018.12.013","volume":"67","author":"X Huang","year":"2019","unstructured":"Huang X, Zhu Z, Guo X, Kong X (2019) The roles of microRNAs in the pathogenesis of chronic obstructive pulmonary disease. Int Immunopharmacol 67:335\u2013347","journal-title":"Int Immunopharmacol"},{"key":"5110_CR63","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.2147\/COPD.S325300","volume":"16","author":"J An","year":"2021","unstructured":"An J, Yang T, Dong J, Liao Z, Wan C, Shen Y, Chen L (2021) Identifying miRNA modules and related pathways of chronic obstructive pulmonary disease associated emphysema by weighted gene co-expression network analysis. Int J Chron Obstruct Pulmon Dis 16:3119","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"5110_CR64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1164\/rccm.201506-1182OC","volume":"195","author":"G Conickx","year":"2017","unstructured":"Conickx G, Mestdagh P, Avila Cobos F et al (2017) MicroRNA profiling reveals a role for microRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 195:43\u201356","journal-title":"Am J Respir Crit Care Med"},{"key":"5110_CR65","first-page":"A4049","volume-title":"B58 BIG AND BIGGER (DATA): OMICS AND BIOMARKERS OF COPD AND OTHER CHRONIC LUNG DISEASES","author":"G Conickx","year":"2016","unstructured":"Conickx G, Mestdagh P, Avila Cobos F et al (2016) Microrna-218-5p is implicated in the pathogenesis of chronic obstructive pulmonary disease. B58 BIG AND BIGGER (DATA): OMICS AND BIOMARKERS OF COPD AND OTHER CHRONIC LUNG DISEASES. American Thoracic Society, pp A4049\u2013A4049"},{"key":"5110_CR66","first-page":"328","volume":"18","author":"Z Cao","year":"2014","unstructured":"Cao Z, Zhang N, Lou T, Jin Y, Wu Y, Ye Z, Pan J (2014) microRNA-183 down-regulates the expression of BKCa\u03b21 protein that is related to the severity of chronic obstructive pulmonary disease. Hippokratia 18:328\u2013332","journal-title":"Hippokratia"},{"key":"5110_CR67","volume":"34","author":"S Liu","year":"2020","unstructured":"Liu S, Liu M, Dong L (2020) The clinical value of lncRNA MALAT1 and its targets miR-125b, miR-133, miR-146a, and miR-203 for predicting disease progression in chronic obstructive pulmonary disease patients. J Clin Lab Anal 34:e23410","journal-title":"J Clin Lab Anal"},{"key":"5110_CR68","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1002\/jcb.27910","volume":"120","author":"Y Sun","year":"2019","unstructured":"Sun Y, An N, Li J, Xia J, Tian Y, Zhao P, Liu X, Huang H, Gao J, Zhang X (2019) miRNA-206 regulates human pulmonary microvascular endothelial cell apoptosis via targeting in chronic obstructive pulmonary disease. J Cell Biochem 120:6223\u20136236","journal-title":"J Cell Biochem"},{"key":"5110_CR69","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23134","volume":"36","author":"S Paul","year":"2022","unstructured":"Paul S, Ruiz-Manriquez LM, Ambriz-Gonzalez H, Medina-Gomez D, Valenzuela-Coronado E, Moreno-Gomez P, Pathak S, Chakraborty S, Srivastava A (2022) Impact of smoking-induced dysregulated human miRNAs in chronic disease development and their potential use in prognostic and therapeutic purposes. J Biochem Mol Toxicol 36:e23134","journal-title":"J Biochem Mol Toxicol"},{"key":"5110_CR70","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2147\/COPD.S156865","volume":"13","author":"PF Liu","year":"2018","unstructured":"Liu PF, Yan P, Zhao DH, Shi WF, Meng S, Liu Y, Liu B, Li GF, Xie LX (2018) The effect of environmental factors on the differential expression of miRNAs in patients with chronic obstructive pulmonary disease: a pilot clinical study. Int J Chron Obstruct Pulmon Dis 13:741\u2013751","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"5110_CR71","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/resp.12644","volume":"21","author":"N Berend","year":"2016","unstructured":"Berend N (2016) Contribution of air pollution to COPD and small airway dysfunction. Respirology 21(2):237\u2013244","journal-title":"Respirology"},{"key":"5110_CR72","doi-asserted-by":"crossref","first-page":"35871","DOI":"10.1038\/srep35871","volume":"6","author":"JR Baker","year":"2016","unstructured":"Baker JR, Vuppusetty C, Colley T, Papaioannou AI, Fenwick P, Donnelly L, Ito K, Barnes PJ (2016) Oxidative stress dependent microRNA-34a activation via PI3K\u03b1 reduces the expression of sirtuin-1 and sirtuin-6 in epithelial cells. Sci Rep 6:35871","journal-title":"Sci Rep"},{"key":"5110_CR73","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1166\/jbn.2023.3497","volume":"19","author":"C Ji","year":"2023","unstructured":"Ji C, Pan H, Zhang J, Zhao Y, Fu K, Zhu X (2023) miR-140 aggravates chronic obstructive pulmonary disease by inducing oxidative stress in diaphragm cells by targeting nuclear factor erythroid 2-related factor 2. J Biomed Nanotechnol 19:98\u2013108","journal-title":"J Biomed Nanotechnol"},{"key":"5110_CR74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/01902148.2018.1439548","volume":"44","author":"Z Zeng","year":"2018","unstructured":"Zeng Z, He S, Lu J, Liu C, Lin H, Xu C, Xie L, Sun S (2018) MicroRNA-21 aggravates chronic obstructive pulmonary disease by promoting autophagy. Exp Lung Res 44:89\u201397","journal-title":"Exp Lung Res"},{"key":"5110_CR75","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12931-021-01630-1","volume":"22","author":"Q Song","year":"2021","unstructured":"Song Q, Chen P, Liu X-M (2021) The role of cigarette smoke-induced pulmonary vascular endothelial cell apoptosis in COPD. Respir Res 22:39","journal-title":"Respir Res"},{"issue":"1","key":"5110_CR76","doi-asserted-by":"crossref","first-page":"31596","DOI":"10.1038\/srep31596","volume":"6","author":"KA Serban","year":"2016","unstructured":"Serban KA, Rezania S, Petrusca DN, Poirier C, Cao D, Justice MJ, Patel M, Tsvetkova I, Kamocki K, Mikosz A, Schweitzer KS (2016) Structural and functional characterization of endothelial microparticles released by cigarette smoke. Sci Rep 6(1):31596","journal-title":"Sci Rep"},{"key":"5110_CR77","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ccm.2013.10.004","volume":"35","author":"PJ Barnes","year":"2014","unstructured":"Barnes PJ (2014) Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med 35:71\u201386","journal-title":"Clin Chest Med"},{"key":"5110_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.608666","author":"JA Ca\u00f1as","year":"2021","unstructured":"Ca\u00f1as JA, Rodrigo-Mu\u00f1oz JM, Sastre B, Gil-Martinez M, Redondo N, del Pozo V (2021) MicroRNAs as potential regulators of immune response networks in asthma and chronic obstructive pulmonary disease. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.608666","journal-title":"Front Immunol"},{"key":"5110_CR79","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12931-016-0486-5","volume":"18","author":"X Dang","year":"2017","unstructured":"Dang X, Qu X, Wang W, Liao C, Li Y, Zhang X, Xu D, Baglole CJ, Shang D, Chang Y (2017) Bioinformatic analysis of microRNA and mRNA regulation in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease. Respir Res 18:4","journal-title":"Respir Res"},{"key":"5110_CR80","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/cells12010067","volume":"12","author":"B Ortiz-Quintero","year":"2023","unstructured":"Ortiz-Quintero B, Mart\u00ednez-Espinosa I, P\u00e9rez-Padilla R (2023) Mechanisms of lung damage and development of COPD due to household biomass-smoke exposure: inflammation, oxidative stress, MicroRNAs, and gene polymorphisms. Cells 12:67","journal-title":"Cells"},{"key":"5110_CR81","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/15592294.2016.1155012","volume":"13","author":"M Tsamou","year":"2018","unstructured":"Tsamou M, Vrijens K, Madhloum N, Lefebvre W, Vanpoucke C, Nawrot TS (2018) Air pollution-induced placental epigenetic alterations in early life: a candidate miRNA approach. Epigenetics 13:135\u2013146","journal-title":"Epigenetics"},{"key":"5110_CR82","doi-asserted-by":"crossref","first-page":"21","DOI":"10.17219\/acem\/28343","volume":"25","author":"M Kara","year":"2016","unstructured":"Kara M, Kirkil G, Kalemci S (2016) Differential expression of MicroRNAs in chronic obstructive pulmonary disease. Adv Clin Exp Med 25:21\u201326","journal-title":"Adv Clin Exp Med"},{"key":"5110_CR83","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1164\/rccm.201706-1304LE","volume":"197","author":"KE Paschalaki","year":"2018","unstructured":"Paschalaki KE, Zampetaki A, Baker JR, Birrell MA, Starke RD, Belvisi MG, Donnelly LE, Mayr M, Randi AM, Barnes PJ (2018) Downregulation of MicroRNA-126 augments DNA damage response in cigarette smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 197:665\u2013668","journal-title":"Am J Respir Crit Care Med"},{"key":"5110_CR84","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13273-017-0022-9","volume":"13","author":"WJ Kim","year":"2017","unstructured":"Kim WJ, Lim JH, Hong Y, Hong SH, Bang CY, Lee JS, Oh YM, Kim JH (2017) Altered miRNA expression in lung tissues of patients with chronic obstructive pulmonary disease. Mol Cell Toxicol 13:207\u2013212","journal-title":"Mol Cell Toxicol"},{"key":"5110_CR85","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e25393","volume":"10","author":"V Jessamine","year":"2024","unstructured":"Jessamine V, Mehndiratta S, De Rubis G, Paudel KR, Shetty S, Suares D, Chellappan DK, Oliver BG, Hansbro PM, Dua K (2024) The application of nanoparticles as advanced drug delivery systems in Attenuating COPD. Heliyon 10:e25393","journal-title":"Heliyon"},{"key":"5110_CR86","doi-asserted-by":"crossref","first-page":"987","DOI":"10.4155\/fmc-2020-0066","volume":"12","author":"M Mehta","year":"2020","unstructured":"Mehta M, Chellappan DK, Wich PR, Hansbro NG, Hansbro PM, Dua K (2020) miRNA nanotherapeutics: potential and challenges in respiratory disorders. Future Med Chem 12:987\u2013990","journal-title":"Future Med Chem"},{"key":"5110_CR87","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1021\/acs.molpharmaceut.1c00491","volume":"18","author":"S Pramanik","year":"2021","unstructured":"Pramanik S, Mohanto S, Manne R, Rajendran RR, Deepak A, Edapully SJ, Patil T, Katari O (2021) Nanoparticle-based drug delivery system: the magic bullet for the treatment of chronic pulmonary diseases. Mol Pharm 18:3671\u20133718","journal-title":"Mol Pharm"},{"key":"5110_CR88","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02830-w","author":"G De Rubis","year":"2023","unstructured":"De Rubis G, Paudel KR, Corrie L et al (2023) Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-023-02830-w","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5110_CR89","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1002\/jps.23300","volume":"101","author":"D Guzman-Villanueva","year":"2012","unstructured":"Guzman-Villanueva D, El-Sherbiny IM, Herrera-Ruiz D, Vlassov AV, Smyth HDC (2012) Formulation approaches to short interfering RNA and MicroRNA: challenges and implications. J Pharm Sci 101:4046\u20134066","journal-title":"J Pharm Sci"},{"key":"5110_CR90","volume":"20","author":"S Sur","year":"2019","unstructured":"Sur S, Rathore A, Dave V, Reddy KR, Chouhan RS, Sadhu V (2019) Recent developments in functionalized polymer nanoparticles for efficient drug delivery system. Nano-Struct Nano-Objects 20:100397","journal-title":"Nano-Struct Nano-Objects"},{"key":"5110_CR91","doi-asserted-by":"crossref","first-page":"5058121","DOI":"10.1155\/2022\/5058121","volume":"2022","author":"J Saxena","year":"2022","unstructured":"Saxena J, Bisen M, Misra A, Srivastava VK, Kaushik S, Siddiqui AJ, Mishra N, Singh A, Jyoti A (2022) Targeting COPD with PLGA-based nanoparticles: current status and prospects. BioMed Res Int 2022:5058121","journal-title":"BioMed Res Int"},{"key":"5110_CR92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2019.01.002","volume":"136","author":"A Mohamed","year":"2019","unstructured":"Mohamed A, Kunda NK, Ross K, Hutcheon GA, Saleem IY (2019) Polymeric nanoparticles for the delivery of miRNA to treat chronic obstructive pulmonary disease (COPD). Eur J Pharm Biopharm 136:1\u20138","journal-title":"Eur J Pharm Biopharm"},{"key":"5110_CR93","first-page":"3907","volume":"8","author":"PJ McKiernan","year":"2013","unstructured":"McKiernan PJ, Cunningham O, Greene CM, Cryan SA (2013) Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology. Int J Nanomed 8:3907\u20133915","journal-title":"Int J Nanomed"},{"key":"5110_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1059343","author":"ME Taghavizadeh Yazdi","year":"2023","unstructured":"Taghavizadeh Yazdi ME, Qayoomian M, Beigoli S, Boskabady MH (2023) Recent advances in nanoparticle applications in respiratory disorders: a review. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1059343","journal-title":"Front Pharmacol"},{"issue":"1","key":"5110_CR95","volume":"2014","author":"E Vasile","year":"2014","unstructured":"Vasile E et al (2014) Direct synthesis and morphological characterization of gold-dendrimer nanocomposites prepared using PAMAM succinamic acid dendrimers: preliminary study of the calcification potential. Sci World J 2014(1):103462","journal-title":"Sci World J"},{"key":"5110_CR96","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12951-020-00703-5","volume":"18","author":"Y Xu","year":"2020","unstructured":"Xu Y, Liu H, Song L (2020) Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review. J Nanobiotechnol 18:145","journal-title":"J Nanobiotechnol"},{"key":"5110_CR97","first-page":"13892","volume":"2021","author":"AS Mishra","year":"2021","unstructured":"Mishra AS, Sugumaran A (2021) Nanoparticulate delivery systems for the effective treatment of COPD. Ann Romanian Soc Cell Biol 2021:13892\u201313904","journal-title":"Ann Romanian Soc Cell Biol"},{"key":"5110_CR98","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1021\/nl5048972","volume":"15","author":"OF Khan","year":"2015","unstructured":"Khan OF, Zaia EW, Jhunjhunwala S et al (2015) Dendrimer-inspired nanomaterials for the in vivo delivery of siRNA to lung vasculature. Nano Lett 15:3008\u20133016","journal-title":"Nano Lett"},{"key":"5110_CR99","volume":"70","author":"L\u00c1 Ibarra-S\u00e1nchez","year":"2022","unstructured":"Ibarra-S\u00e1nchez L\u00c1, G\u00e1mez-M\u00e9ndez A, Mart\u00ednez-Ruiz M, N\u00e1jera-Mart\u00ednez EF, Morales-Flores BA, Melchor-Mart\u00ednez EM, Sosa-Hern\u00e1ndez JE, Parra-Sald\u00edvar R, Iqbal HMN (2022) Nanostructures for drug delivery in respiratory diseases therapeutics: revision of current trends and its comparative analysis. J Drug Deliv Sci Technol 70:103219","journal-title":"J Drug Deliv Sci Technol"},{"key":"5110_CR100","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.1074\/jbc.M115.693671","volume":"291","author":"PO Yoon","year":"2016","unstructured":"Yoon PO, Park JW, Lee C-M et al (2016) Self-assembled Micelle interfering RNA for effective and safe targeting of dysregulated genes in pulmonary fibrosis. J Biol Chem 291:6433\u20136446","journal-title":"J Biol Chem"},{"key":"5110_CR101","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2020.102303","volume":"31","author":"M Mehta","year":"2021","unstructured":"Mehta M, Satija S, Paudel KR, Malyla V, Kannaujiya VK, Chellappan DK, Bebawy M, Hansbro PM, Wich PR, Dua K (2021) Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: current status and future perspectives. Nanomed Nanotechnol Biol Med 31:102303","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"5110_CR102","doi-asserted-by":"crossref","first-page":"2200018","DOI":"10.1002\/adtp.202200018","volume":"5","author":"Y Liu","year":"2022","unstructured":"Liu Y, Sukumar UK, Jugniot N, Seetharam SM, Rengaramachandran A, Sadeghipour N, Mukherjee P, Krishnan A, Massoud TF, Paulmurugan R (2022) Inhaled gold nano-star carriers for targeted delivery of triple suicide gene therapy and therapeutic MicroRNAs to lung metastases: development and validation in a small animal model. Adv Ther 5:2200018","journal-title":"Adv Ther"},{"key":"5110_CR103","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2021.102388","volume":"34","author":"SM Niemiec","year":"2021","unstructured":"Niemiec SM, Hilton SA, Wallbank A et al (2021) Cerium oxide nanoparticle delivery of microRNA-146a for local treatment of acute lung injury. Nanomed Nanotechnol Biol Med 34:102388","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"5110_CR104","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s12551-017-0319-x","volume":"9","author":"AL da Silva","year":"2017","unstructured":"da Silva AL, Cruz FF, Rocco PRM, Morales MM (2017) New perspectives in nanotherapeutics for chronic respiratory diseases. Biophys Rev 9:793\u2013803","journal-title":"Biophys Rev"},{"key":"5110_CR105","first-page":"1","volume":"2024","author":"C Duraloglu","year":"2024","unstructured":"Duraloglu C, Baysal I, Yabanoglu-Ciftci S, Arica B (2024) Nintedanib and miR-29b co-loaded lipoplexes in idiopathic pulmonary fibrosis: formulation, characterization, and in vitro evaluation. Drug Dev Ind Pharm 2024:1\u201316","journal-title":"Drug Dev Ind Pharm"},{"key":"5110_CR106","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1021\/mp2002076","volume":"8","author":"Y Wu","year":"2011","unstructured":"Wu Y, Crawford M, Yu B, Mao Y, Nana-Sinkam SP, Lee LJ (2011) MicroRNA delivery by cationic lipoplexes for lung cancer therapy. Mol Pharm 8:1381\u20131389","journal-title":"Mol Pharm"},{"key":"5110_CR107","first-page":"4481","volume":"8","author":"H-Y Lee","year":"2013","unstructured":"Lee H-Y, Mohammed KA, Kaye F, Sharma P, Moudgil BM, Clapp WL, Nasreen N (2013) Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer. Int J Nanomed 8:4481\u20134494","journal-title":"Int J Nanomed"},{"key":"5110_CR108","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.omtn.2023.02.031","volume":"32","author":"L Yan","year":"2023","unstructured":"Yan L, Su Y, Hsia I, Xu Y, Vincent-Chong VK, Mojica W, Seshadri M, Zhao R, Wu Y (2023) Delivery of anti-microRNA-21 by lung-targeted liposomes for pulmonary fibrosis treatment. Mol Ther Nucleic Acids 32:36\u201347","journal-title":"Mol Ther Nucleic Acids"},{"key":"5110_CR109","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s00432-019-03051-6","volume":"145","author":"Q Jiang","year":"2019","unstructured":"Jiang Q, Yuan Y, Gong Y, Luo X, Su X, Hu X, Zhu W (2019) Therapeutic delivery of microRNA-143 by cationic lipoplexes for non-small cell lung cancer treatment in vivo. J Cancer Res Clin Oncol 145:2951\u20132967","journal-title":"J Cancer Res Clin Oncol"},{"key":"5110_CR110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41467-020-20449-w","volume":"12","author":"CM Bobba","year":"2021","unstructured":"Bobba CM, Fei Q, Shukla V et al (2021) Nanoparticle delivery of microRNA-146a regulates mechanotransduction in lung macrophages and mitigates injury during mechanical ventilation. Nat Commun 12:289","journal-title":"Nat Commun"},{"key":"5110_CR111","volume":"56","author":"PP Mehta","year":"2020","unstructured":"Mehta PP, Ghoshal D, Pawar AP, Kadam SS, Dhapte-Pawar VS (2020) Recent advances in inhalable liposomes for treatment of pulmonary diseases: concept to clinical stance. J Drug Deliv Sci Technol 56:101509","journal-title":"J Drug Deliv Sci Technol"},{"key":"5110_CR112","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/13543776.2019.1679767","volume":"29","author":"MM El-Hammadi","year":"2019","unstructured":"El-Hammadi MM, Arias JL (2019) An update on liposomes in drug delivery: a patent review (2014\u20132018). Expert Opin Ther Pat 29:891\u2013907","journal-title":"Expert Opin Ther Pat"},{"key":"5110_CR113","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/pharmaceutics13020177","volume":"13","author":"Y Xu","year":"2021","unstructured":"Xu Y, Thakur A, Zhang Y, Foged C (2021) Inhaled RNA therapeutics for obstructive airway diseases: recent advances and future prospects. Pharmaceutics 13:177","journal-title":"Pharmaceutics"},{"key":"5110_CR114","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00161-2018","author":"S Vencken","year":"2019","unstructured":"Vencken S, Foged C, Ramsey JM, Sweeney L, Cryan S-A, MacLoughlin RJ, Greene CM (2019) Nebulised lipid\u2013polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00161-2018","journal-title":"ERJ Open Res"},{"issue":"3","key":"5110_CR115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-155-3-201108020-00008","volume":"155","author":"A Qaseem","year":"2011","unstructured":"Qaseem A et al (2011) Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 155(3):179\u2013191","journal-title":"Ann Intern Med"},{"key":"5110_CR116","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118524","volume":"569","author":"A Mohamed","year":"2019","unstructured":"Mohamed A, Pekoz AY, Ross K, Hutcheon GA, Saleem IY (2019) Pulmonary delivery of nanocomposite microparticles (NCMPs) incorporating miR-146a for treatment of COPD. Int J Pharm 569:118524","journal-title":"Int J Pharm"},{"key":"5110_CR117","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3390\/molecules22010139","volume":"22","author":"W Liao","year":"2017","unstructured":"Liao W, Dong J, Peh HY, Tan LH, Lim KS, Li L, Wong WSF (2017) Oligonucleotide therapy for obstructive and restrictive respiratory diseases. Molecules 22:139","journal-title":"Molecules"},{"key":"5110_CR118","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cbi.2019.05.028","volume":"308","author":"M Mehta","year":"2019","unstructured":"Mehta M, Deeksha TD et al (2019) Oligonucleotide therapy: an emerging focus area for drug delivery in chronic inflammatory respiratory diseases. Chem Biol Interact 308:206\u2013215","journal-title":"Chem Biol Interact"},{"key":"5110_CR119","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4155\/fmc.11.108","volume":"3","author":"N Ferrari","year":"2011","unstructured":"Ferrari N, Seguin R, Renzi P (2011) Oligonucleotides: a multi-targeted approach for the treatment of respiratory diseases. Future Med Chem 3:1647\u20131662","journal-title":"Future Med Chem"},{"key":"5110_CR120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s13346-016-0343-6","volume":"7","author":"K Dua","year":"2017","unstructured":"Dua K, Hansbro NG, Foster PS, Hansbro PM (2017) MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases. Drug Deliv Transl Res 7:168\u2013178","journal-title":"Drug Deliv Transl Res"},{"key":"5110_CR121","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.3390\/ijms20163938","volume":"20","author":"G Murdaca","year":"2019","unstructured":"Murdaca G, Tonacci A, Negrini S, Greco M, Borro M, Puppo F, Gangemi S (2019) Effects of AntagomiRs on different lung diseases in human, cellular, and animal models. Int J Mol Sci 20:3938","journal-title":"Int J Mol Sci"},{"key":"5110_CR122","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1096\/fj.201800965R","volume":"33","author":"JR Baker","year":"2019","unstructured":"Baker JR, Vuppusetty C, Colley T, Hassibi S, Fenwick PS, Donnelly LE, Ito K, Barnes PJ (2019) MicroRNA-570 is a novel regulator of cellular senescence and inflammaging. FASEB J 33:1605\u20131616","journal-title":"FASEB J"},{"key":"5110_CR123","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12931-024-02696-3","volume":"25","author":"F Lu","year":"2024","unstructured":"Lu F, Yao L, Gao D et al (2024) MicroRNA-377-3p exacerbates chronic obstructive pulmonary disease through suppressing ZFP36L1 expression and inducing lung fibroblast senescence. Respir Res 25:67","journal-title":"Respir Res"},{"key":"5110_CR124","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tips.2020.04.007","volume":"41","author":"D Mei","year":"2020","unstructured":"Mei D, Tan WSD, Tay Y, Mukhopadhyay A, Wong WSF (2020) Therapeutic RNA strategies for chronic obstructive pulmonary disease. Trends Pharmacol Sci 41:475\u2013486","journal-title":"Trends Pharmacol Sci"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-05110-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-024-05110-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-05110-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T13:18:42Z","timestamp":1740057522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-024-05110-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":124,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["5110"],"URL":"https:\/\/doi.org\/10.1007\/s11010-024-05110-0","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}